79 related articles for article (PubMed ID: 21528270)
1. Production and characterization of a monoclonal antibody (MSN-3) for uterine endometrial and endocervical adenocarcinoma.
Hasegawa K; Tsukazaki K; Kubushiro K; Kobayashi Y; Kobiki K; Udagawa Y; Nozawa S
Int J Oncol; 1997 Oct; 11(4):749-56. PubMed ID: 21528270
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of anti human uterine endometrial cancer antibody (MSN-1) and its usefulness in clinical application].
Tsukazaki K; Sakuma Y; Kaneta Y; Sakayori M; Uchiyama M; Nozawa S
Gan To Kagaku Ryoho; 1994 Feb; 21(2):141-9. PubMed ID: 8311483
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma].
Ohwada M; Suzuki M; Tamada T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1237-43. PubMed ID: 2212824
[TBL] [Abstract][Full Text] [Related]
4. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
5. [Production of monoclonal antibody against a newly established human endometrial cancer cell line SNG-II].
Nozawa S; Sakayori M; Takayama Y; Tsukazaki K; Aoki D; Iizuka R; Mukai M; Inaba N
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):559-66. PubMed ID: 3295079
[TBL] [Abstract][Full Text] [Related]
6. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
7. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma.
McCluggage WG; Jenkins D
Int J Gynecol Pathol; 2003 Jul; 22(3):231-5. PubMed ID: 12819388
[TBL] [Abstract][Full Text] [Related]
8. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
[TBL] [Abstract][Full Text] [Related]
9. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
10. Effects of gelonin immunoconjugate of monoclonal antibody MSN-1 to endometrial adenocarcinoma on antigen-producing tumor cells in vitro.
Kaneta Y; Tsukazaki K; Kubushiro K; Aoki R; Sakayori M; Ueda M; Nozawa S
Oncol Rep; 1997; 4(2):331-6. PubMed ID: 21590053
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of cell surface antigen recognized by monoclonal antibody (MSN-1) in normal, hyperplasia, and carcinoma of endometrial cells: its diagnostic value for endometrial carcinoma.
Kobayashi Y; Tsukazaki K; Ohta K; Mikami M; Kubushiro K; Nozawa S
Cytometry; 1997 Feb; 30(1):23-7. PubMed ID: 9056738
[TBL] [Abstract][Full Text] [Related]
12. Subcellular localization of blood group Leb carbohydrate antigen (MSN-1-reactive antigen) in endometrial cancer cells.
Susumu N; Kawakami H; Aoki D; Hirano H; Nozawa S
Cancer Res; 1993 Aug; 53(15):3643-8. PubMed ID: 8339270
[TBL] [Abstract][Full Text] [Related]
13. Endometrial and endocervical secretion: the search for histochemical differentiation.
Nieuwenhuizen L; Khalil MK; Venkatesh N; Othman NH
Anal Quant Cytol Histol; 2006 Apr; 28(2):87-96. PubMed ID: 16637511
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
15. [The production and characterization of monoclonal antibody, 1C5, reactive with cervical adenocarcinoma of the uterus].
Koizumi M; Uede T; Kudo R
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):530-6. PubMed ID: 2474040
[TBL] [Abstract][Full Text] [Related]
16. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody (MSN-1) against a newly established uterine endometrial cancer cell line (SNG-II) and its application to immunohistochemistry and flow cytometry.
Nozawa S; Sakayori M; Ohta K; Iizuka R; Mochizuki H; Soma M; Fujimoto J; Hata J; Iwamori M; Nagai Y
Am J Obstet Gynecol; 1989 Oct; 161(4):1079-86. PubMed ID: 2478021
[TBL] [Abstract][Full Text] [Related]
18. [Development of the monoclonal antibody to cultured uterine endometrial adenocarcinoma cells (EI)].
Yudate T; Isaka K; Okabe K; Takayama M
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):635-42. PubMed ID: 7636334
[TBL] [Abstract][Full Text] [Related]
19. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia.
Umezaki K; Sanezumi M; Okada H; Okamura A; Tsubra A; Kanazaki H
Gynecol Oncol; 1997 Sep; 66(3):393-8. PubMed ID: 9299251
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
